[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Azienda Ospedaliero, Universitaria Ospedali Riuniti\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":97},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,70],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100599565","efficacy-of-a-myocardial-panel-in-the-management-and-treatment-of-pediatric-myocarditis-100599565",false,"NCT07086144","Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric Myocarditis","Efficacy of a Myocardial Panel (Virological, Bacterial and Autoimmune) in the Management and Treatment of Pediatric Myocarditis Complicated With Arrhythmias or Ventricular Dysfunction","Inclusion Criteria:\n\n* All the consecutive pediatric patients (\\\u003C 18 years old) presenting with myocarditis complicated by arrhythmias or myocardial dysfunction\n\nExclusion Criteria:\n\n* Refused consent to be included in the study given by parents or legal tutors\n* Uncomplicated myocarditis presenting without arrhythmias or myocardial dysfunction","ALL","18 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this observational study is to determine the efficacy a of combined management and treatment driven by the systematic determination of viral genome, bacterial serology, and markers of inflammation in pediatric patients (\\\u003C 18 years old) diagnosed with myocarditis complicated by arrhythmias (supraventricular and ventricular tachycardias and heart block) or ventricular dysfunction (left ventricular ejection fraction \\\u003C 50% or right ventricular fractional area change \\\u003C 35%).\n\nThe main question it aims to answer is: Does this panel help resolve arrhythmias or myocardial dysfunction due to myocarditis during hospitalisation and follow-up?\n\nResearchers will compare patients managed and treated in 2024 without applying the myocarditis panel with those enrolled in 2025 who received the panel. Arrhythmias and myocardial dysfunction will be managed in accordance with recent guidelines. Antiviral, antibiotic or immunosuppressive therapies will be implemented in addition to standard therapy when required by the panel.",[26],"Myocarditis",[28,29,30,31,32],"pediatric myocarditis","Arrhythmias","Myocarditis panel","Etiological therapy","Myocardial dysfunction","RECRUITING","2025-07-18",{"date":36,"type":37},"2025-07-25","ACTUAL",{"date":39,"type":37},"2024-01-01",{"date":41,"type":20},"2028-12-31",{"name":43,"class":44},"Azienda Ospedaliero, Universitaria Ospedali Riuniti","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":57,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":45},"100544613","rivaroxaban-for-intracardiac-thrombosis-in-the-pediatric-population-100544613","NCT06371170","Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population","Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population at Different Cardiac Sites","Inclusion Criteria:\n\n* Intracardiac thrombosis demonstration at echocardiography and CMR\u002FCCT confirmation\n* Given informed consent from the parents or tutors\n\nExclusion Criteria:\n\n* \\\u003C 38 weeks of gestational birth\n* \\\u003C 10 days of oral feeding and body weight\n* \\\u003C 2.6 Kg\n* Any major or clinically relevant bleeding event or abnormal coagulation test results within 10 days prior to the enrollment for the whole population","1 Month","16 Years",{"count":56,"type":20},20,"6 Months","OBSERVATIONAL","The goal of this observational study is to determine the efficacy of rivaroxaban treatment for intracardiac thrombi resolution in pediatric patients (\\\u003C 16 years old) diagnosed with intracardiac thrombosis. The main question it aims to answer is: Does rivaroxaban treatment resolve the thrombosis during a 3-month treatment?\n\nParticipants already taking rivaroxaban as part of their regular medical care for thrombosis resolution. They will undergo monthly visits to check that the treatment is progressing correctly and that no major bleeding has occurred. After 3 months of treatment, they will repeat the radiological imaging investigation to verify the actual resolution of the thrombosis.",[61],"Intracardiac Thrombus","2024-04-17",{"date":64,"type":37},"2024-04-19",{"date":66,"type":37},"2023-01-01",{"date":68,"type":20},"2027-01-01",{"name":43,"class":44},{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":78,"sex":16,"minAge":79,"maxAge":4,"enrollmentInfo":80,"targetDuration":82,"studyType":58,"phases":4,"briefSummary":83,"conditions":84,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":45},"100461457","repaired-tetralogy-of-fallot-italian-registry-100461457","NCT05288894","Repaired Tetralogy of Fallot Italian Registry","Multicenter Italian Registry From the Italian Pediatric Cardiology Society (SICP) Working Group (WG) on CMR\u002FCT for the Repaired Tetralogy of Fallot","RETE-Fallot","Inclusion Criteria:\n\n* Patients with Repaired - TOF\n\nExclusion Criteria:\n\n* Age \\\u003C 10 years\n* Other associated complex pathology such as MAPCAs, Atrioventricular canal, Ebstein\n* Incomplete CMR exam",true,"10 Years",{"count":81,"type":20},150,"6 Years","The CMR\u002FCT WG of the Italian pediatric cardiology society set up a multi-center observational clinical database of repaired-TOF evaluated. This registry will enroll prospectively patients evaluated by CMR for clinical indication in most of the CHD Italian centers. Data collection will include surgical history, clinical data, imaging data, and also adverse cardiac events for a period of 6 years.",[85,86,87,88],"Tetralogy of Fallot","Cardiac Death, Sudden","Cardiac Arrhythmia","Cardiac Event","2024-04-15",{"date":91,"type":37},"2024-04-16",{"date":93,"type":37},"2021-03-01",{"date":95,"type":20},"2027-03",{"name":43,"class":44},""]